Teva Pharmaceuticals Industries Ltd. (TEVA, TEVA.TV) confirmed that its Paris offices were visited by European Commission investigators, saying it is part of a broader antitrust probe of generic practices in France.

The European Union's executive arm earlier Tuesday said it has been conducting surprise searches at several companies operating in the pharmaceutical industry as a preliminary step in an antitrust probe.

The commission, the European Union's executive arm, didn't name any of the companies involved, but French drug maker Sanofi-Aventis (SNY, SAN.FR) is the only company that has confirmed that it was one of the companies raided.

A U.S.-based spokeswoman from Teva, an Israeli generic drug giant that has numerous operations across Europe, said the company is providing full support to commission officials during the inquiry.

"In any event, we believe that Teva France has conducted its business in a responsible manner," she said.

-Thomas Gryta; Dow Jones Newswires; 212-416-2169; thomas.gryta@dowjones.com

(Mimosa Spencer in Paris contributed to this article.)